Focus on new skills for new roles

'The Future of Health: Focus on Biosimilars' explores some of the key questions associated with unlocking the potential benefits of biosimilar medicines in the NHS.  This course is designed to equip researchers with better understanding of this new class of medicines.

On completion of this short e-learning programme you will:

- understand the key concepts

- be able to keep up-to-date with future developments, and 

- be able to confidently explain in lay terms relevant information to patients, carers and the public.  

'The Future of Health: Focus on Cell and Gene Therapy' explores some of the key questions associated with 'advanced therapies' (often referred to as Cell & Gene Therapy or ATMPs).  This course is designed to equip the research delivery workforce with a better understanding of these innovations. This module has been developed by the National Institute for Health Research with support from Cell and Gene Therapy Catapult UK.  

On completion of this short e-learning programme you will:

  • Explain the key concepts of cell and gene therapy
  • Identify options for gaining deeper current knowledge, and  for keeping up-to-date with future developments,  of cell and gene therapy
  • Give examples of the practicalities and preparations required for delivering clinical trials in gene and cell therapy
  • Be able to confidently discuss, in lay terms, the key considerations, benefits and impacts of cell and gene therapy that are relevant to patients, the health system and the public.    

This course is designed to equip researchers with the practical skills to recruit patients into randomised surgical trials.  Researchers involved in any randomised controlled trial (RCT) may also find it helpful to draw upon these insights from surgical clinical studies. 

It will focus on the concept of ‘equipoise’, which means uncertainty over which treatment is best. Learners are taught to communicate this uncertainty to patients and the need to assess it within a trial. This means patients will be more likely to understand clinical research and to consent to take part in surgical trials.  The course has been created through the collaboration of the University of Bristol's QuinteT research group and MRC ConDuCT-II hub; the University of Birmingham's academic department of surgery and Cancer Research UK clinical trials unit; and other stakeholders.

By completing this course you will:

- understand why we need randomised controlled surgical trials

- understand how to convey clinical equipoise, explain randomisation and address patient preferences

- be able to successfully recruit to randomised controlled trials in surgery

NOTE: On completing this on-line programme you may find it helpful to attend further skills-practice sessions offered by GRANULE

The UK has been prominent in developing the field of metabolic phenotyping and has pioneered the application of large-scale metabolic phenotyping in epidemiology and clinical medicine. 

This e-learning training program is designed to enhance current capacity for practical utilisation of this technology by transferring knowledge in an efficient manner to those with limited time availability, including NHS clinicians and research personnel. 

Within this e-learning environment, course material comprises short (5-15 minute) modules covering basic steps that are important for conducting metabolic profiling studies. This starts with an introduction to metabolic phenotyping, followed by selecting the appropriate study design, choosing the right analytical platform, multivariate statistical analysis through to biomarker identification strategies.

We hope that you find this course interesting and useful. If you would like to receive further training please get in touch with us here: If you are interested in performing a metabolic phenotyping study and you would like to work with us, please get in touch with us here and we will help you with your experimental design and analysis strategy.